Trupanion
TRUP Small CapFinancial Services · Insurance - Property & Casualty
Mis à jour: Jun 18, 2026, 22:21 UTC
Price Chart
Indicateurs clés
Valuation Analysis
About the Company
Trupanion en bref
Trupanion (TRUP) is currently trading at 20,54 € with a market capitalization of 896 M €. The trailing P/E ratio stands at 39.9x, with a forward P/E of 5.46x. The 52-week range spans from 18,47 € to 50,51 €; the current price is 59.3% below the yearly high. Year-over-year revenue growth stands at +12.3%. The net profit margin stands at 1.74%.
💰 Dividende
Trupanion currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.
📊 Avis des analystes
4 analystes évaluent Trupanion (TRUP) au consensus : Acheter. L'objectif de cours moyen est de 34,69 €, soit un potentiel de +68.86% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 24,43 € à 45,38 €.
Trupanion : la thèse d'investissement en détail
Trupanion (TRUP) operates in the Financial Services — specifically Insurance - Property & Casualty — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.
Le scénario haussier
Revenue is growing at a healthy 12.3% pace year-over-year, suggesting the business model continues to find new customers and pricing power. Wall Street consensus sits at Buy with an average price target implying roughly 68.86% upside from current levels — analyst sentiment is firmly constructive.
Le scénario baissier
With a net margin of just 1.74%, the business has little room to absorb cost shocks or pricing pressure — a single bad quarter can swing the company to a loss. Short interest sits at 10.76% of float — a meaningful contingent of professionals is positioned for the share to fall, which deserves attention even if their thesis may turn out to be wrong. Our valuation screen flags the stock as overvalued — current multiples imply the business needs to deliver well above its recent trajectory to justify the price.
À surveiller
- The forward P/E of 5.46x is meaningfully below the trailing 39.9x — analysts expect earnings to step up; the next earnings release is the test.
- The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
- The analyst consensus price target implies 68.86% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.
Thèse d'investissement : forces et faiblesses
- Consensus des analystes : Buy
- Bilan solide avec faible endettement (D/E 27.7)
- –Faible rentabilité (marge 1.74%)
- –Actuellement jugée surévaluée
- –Positions vendeuses élevées (10.76%)
- –Free cash flow négatif
Aperçu technique
Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).
Profil de risque
The data points to market-like volatility, elevated short interest (10.76%).
Trading Data
Related Stocks in the Same Sector
More Services Financiers stocks
Top peers in the same sector — ranked by market cap.
Where can I buy Trupanion?
Compare top-rated brokers — low fees, trusted providers, fully regulated.
Live Market Data
Real-time chart, financials, earnings, analysts, insider trades, events & news
